ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

PRPH ProPhase Labs Inc

5.42
0.11 (2.07%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ProPhase Labs Inc PRPH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.11 2.07% 5.42 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.30 5.20 5.50 5.42 5.31
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:00GLOBEPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL..
25/4/202407:00GLOBEProPhase Labs to Present at the Planet MicroCap Showcase:..
16/4/202407:00GLOBEProPhase Labs Unveils Project ZenQ-AI
10/4/202407:00GLOBEProPhase Labs Seeks to Transform Esophageal Cancer Detection..
01/4/202420:00GLOBEProPhase Labs Announces Inducement Grant Under Nasdaq..
15/3/202407:00GLOBEProPhase Labs Announces Financial Results for the Year Ended..
08/3/202407:00GLOBEPROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON..
20/2/202407:00GLOBEProPhase Labs Announces Significant Progress in BE-Smart..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:00GLOBEProPhase Labs Announces Preliminary Positive Results for..
30/1/202407:00GLOBEProPhase Labs Ushers in New Genomics Era with Jason Karkus..
23/1/202407:00GLOBEPharmaloz Manufacturing Accelerates Expansion, Improves..
04/1/202407:05EDGAR2Form 8-K - Current report
04/1/202407:00GLOBEProPhase poised to ramp up growth at Pharmaloz and Nebula..
13/11/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202307:00EDGAR2Form 8-K - Current report
09/11/202307:00GLOBEProPhase Labs Announces Financial Results for the Three..
02/11/202307:00GLOBEProPhase Labs to Host Third Quarter 2023 Financial Results..
17/10/202307:00GLOBEProPhase Labs Announces Substantial Growth Expectations for..
12/10/202307:25GLOBEDSS Inc. Issues Letter to Shareholders
12/10/202307:00GLOBEProPhase Labs to Present at The ThinkEquity Conference
11/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202309:40GLOBEProPhase Labs Announces Updated Conference Call Dial-in..
10/8/202307:00EDGAR2Form 8-K - Current report
10/8/202307:00GLOBEProPhase Labs Announces Financial Results for the Three..
03/8/202307:00GLOBEProPhase Labs Teams up with Certis Oncology to Accelerate..
02/8/202307:00GLOBEProPhase Labs to Host Second Quarter 2023 Financial Results..
29/6/202307:05EDGAR2Form 8-K - Current report
29/6/202307:00GLOBENavidea Biopharmaceuticals Rejects ProPhase Labs Offer To..
22/6/202307:30GLOBEProPhase Labs Inc. Sets the Course for Expansion into the..
07/6/202307:00GLOBEProPhase Labs to Present at the Diamond Equity Research..
01/6/202307:30GLOBEProPhase Labs’ Cancer Therapeutic, Linebacker-1,..
11/5/202307:00GLOBEProPhase Labs Announces Financial Results for the Three..
08/5/202307:30GLOBEProPhase Labs hires Dr. Matthew Halpert to Drive Company’s..

Su Consulta Reciente

Delayed Upgrade Clock